Italy
# |
Name |
Price to Earnings Ratio (P/E) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
36.53 |
Feb. 5, 2025 | USD 9.97 | 0.35% |
|
Italy |
|
2 |
36.35 |
Feb. 5, 2025 | USD 53.58 | -1.47% |
|
Italy |
|
3 |
32.54 |
Feb. 5, 2025 | USD 107.00 | 0.25% |
|
Italy |
|
4 |
29.78 |
Feb. 5, 2025 | USD 61.85 | 0.84% |
|
Italy |
|
5 |
10.90 |
Feb. 5, 2025 | USD 1.99 | -0.79% |
|
Italy |
|
6 |
-11.73 |
Feb. 5, 2025 | USD 10.86 | 4.76% |
|
Italy |
|
7 |
-113.49 |
Feb. 5, 2025 | USD 19.14 | -0.29% |
|
Italy |
The Healthcare company in Italy with the highest Price to Earnings Ratio (P/E) is GPI S.p.A. (Milan Stock Exchange: GPI.MI) at 36.53.
The Healthcare company in Italy with the lowest Price to Earnings Ratio (P/E) is Philogen S.p.A. (Milan Stock Exchange: PHIL.MI) at -113.49.
The top 10 Healthcare companies in Italy by Price to Earnings Ratio (P/E) are GPI S.p.A., Pharmanutra S.p.A., DiaSorin S.p.A., Recordati Industria Chimica e Farmaceutica S.p.A., Arterra Bioscience, Newron Pharmaceuticals S.p.A. and Philogen S.p.A..
The bottom 10 Healthcare companies in Italy by Price to Earnings Ratio (P/E) are Philogen S.p.A., Newron Pharmaceuticals S.p.A., Arterra Bioscience, Recordati Industria Chimica e Farmaceutica S.p.A., DiaSorin S.p.A., Pharmanutra S.p.A. and GPI S.p.A..